Baxano is also in the process of developing the iO-Tome precision facetectomy instrument.
TranS1 executives said the acquisition will help the company grow its minimally invasive spine procedure market presence.
More Articles on Devices:
14 News Updates for Spine & Orthopedic Device Companies
Orthopedic Product Sales Exceed $43B in 2012
FDA Grants Priority Review, Biologics License Application to Metabolic Disease
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
